{"id":"cu104","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Further information on CU104's mechanism of action is not available.","oneSentence":"CU104 is an investigational drug with unknown mechanism of action.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T03:29:47.133Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05907330","phase":"PHASE2","title":"Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"Curacle Co., Ltd.","startDate":"2024-06-01","conditions":"Ulcerative Colitis","enrollment":45}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CU104","genericName":"CU104","companyName":"Curacle Co., Ltd.","companyId":"curacle-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}